TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases

Cancers - Switzerland
doi 10.3390/cancers12040868
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Pharmacotherapy With Pamidronate Disodium of Osteolytic Bone Metastases of Breast Cancer, Osteolytic Lesions of Multiple Myeloma, and Paget's Disease

Clinical Medicine. Therapeutics
2009English

Hypoxia and Hypoxia-Inducible Factor-1 Expression Enhance Osteolytic Bone Metastases of Breast Cancer

Cancer Research
Cancer ResearchOncology
2007English

Implications for Osteolytic Bone Metastases

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

Gene Therapy for Osteolytic Breast Cancer Bone Metastasis

2007English

Gene Therapy for Osteolytic Breast Cancer Bone Metastasis

2009English

Matrix Rigidity Induces Osteolytic Gene Expression of Metastatic Breast Cancer Cells

PLoS ONE
Multidisciplinary
2010English

Metalloproteinases and Osteoblast EGFR Signaling in Osteolytic Bone Metastasis of Breast Cancer

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2009English

PTHrP and Breast Cancer: More Than Hypercalcemia and Bone Metastases

Breast Cancer Research
Cancer ResearchOncology
2012English

Strategies for Treatment of Bone Metastases From Breast Cancer

2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy